Needham Maintains Buy on Evolent Health, Raises Price Target to $5
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Needham analyst Matthew Shea maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $4 to $5.
Needham analyst Matthew Shea maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $4 to $5.